You are here: Industry Insights > Vaccines

News List

Sanofi ups the ante in vaccines with new €350M plant fiercepharma
April 18, 2018
Sanofi CEO Olivier Brandicourt took a hard look at the French drugmaker's operations after he took the helm—and he put its vaccines business front and center in the company's growth plans.
Merck Helps Accelerate Global Access to Affordable Vaccines prnasia
April 13, 2018
Merck, a leading science and technology company today announced a partnership with Oxford University's Jenner Institute to develop more robust and scalable vaccine manufacturing processes.
CEPI grants Themis $37.5M for Lassa and MERS vaccines fiercepharma
March 08, 2018
CEPI signed its first company agreement, granting Themis an investment of up to $37.5 million to develop new vaccines against Lassa fever and MERS.
New initiative to accelerate development of universal influenza vaccines europeanpharmaceuticalreview
October 30, 2017
Universal Influenza Vaccine Initiative will address the underlying scientific barrier impeding the development of broadly protective, universal influenza vaccines…
News of Note—VBI Vaccines, BiondVax and more fiercepharma
September 06, 2017
VBI Vaccines won FDA approval for its phase 3 program of hep B shot Sci-B-Vac. Enrollment is expected to start this year in the U.S., Europe and Canada. The vaccine is already licensed in Israel and 14 other countries. Release
Boosting immunotherapy by targeting cells’ recycling centers fiercebiotech
August 29, 2017
Memory T cells can be boosted with a drug normally used to prevent transplanted organs from being rejected, UCSD researchers found.
GSK opens new aluminium salts facility in Scotland pharmatimes.
August 17, 2017
GlaxoSmithKline has officially opened a new £44 million aluminium salts facility in Montrose, Scotland, which is set to supply ingredients for around 400 million vaccines a year
A vaccine for addiction? Don’t get your hopes up just yet: expert fiercepharma
August 15, 2017
Tom Price says an NIH vaccine for addiction is "an incredibly exciting prospect," but experts say it's far from reality.
Takeda, Biological E ink pact to develop and commercialize vaccines biospectrumasia
June 28, 2017
As per the terms, BE has rights to use Takeda's measles vaccine technology for a combination MR vaccine, pertussis vaccine technology for any pertussis-containing combination vaccine
EU nations urge funding to research new drugs and vaccines for tuberculosis pharmaceutical-technology
May 17, 2017
Leaders representing the French and Netherlands governments have urged for funding to develop new treatment and prevention tools against drug-resistant tuberculosis (TB) at a meeting held in Brussels.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 13 14 Next page